Lineage Cell Therapeutics, Inc. Common Stock (LCTX)
Gross Profit Growth
18.69%
TTM · Period ending:
LCTX Gross Profit Growth
Year-over-year change vs the same period a year earlier
Latest reported18.69%period ending
Latest reported18.69%period ending
LCTX TTM Gross Profit YoY % (-33.33% → 18.69%)
Year-over-year change
High-resolution chart · PNG
LCTX gross profit growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Gross Profit Growth |
|---|---|
| -11.7423% | |
| -81.159% | |
| -88.7515% | |
| -92.1973% | |
| -88.381% | |
| -24.4245% | |
| 9.0909% | |
| 36.3636% | |
| 42.8571% | |
| 266.6667% | |
| 266.6667% | |
| 133.3333% | |
| 133.3333% | |
| 0% | |
| 200% | |
| 200% | |
| 200% | |
| 200% | |
| -66.6667% | |
| -66.6667% | |
| -66.6667% | |
| 0% | |
| 400% | |
| 200% | |
| 175% | |
| 125% | |
| 66.6667% | |
| 0% | |
| -33.3333% |